Pieris Pharmaceuticals Inc (NASDAQ:PIRS)
| 0.7887 Delayed Data As of May 26 |  -0.07 / -8.54%Today’s Change | 0.72 Today|||52-Week Range 2.12 | -24.16% Year-to-Date |
Latest PIRS News | Press Releases
No recent news for Pieris Pharmaceuticals Inc.
Today’s Trading
| Previous close | 0.82 |
| Today’s open | 0.82 |
| Day’s range | 0.75 - 0.89 |
| Volume | 758,195 |
| Average volume (3 months) | 549,221 |
| Market cap | $61.5M |
Data as of 3:59pm ET, 05/26/2023
Growth & Valuation
| Earnings growth (last year) | +36.69% |
| Earnings growth (this year) | -56.67% |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | -17.56% |
| P/E ratio | NM |
| Price/Sales | 2.98 |
| Price/Book | 2.00 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| DYAIDyadic International... | +0.13 | +6.31% |
| ASLNAslan Pharmaceutical... | -0.03 | -0.76% |
| FIXXHomology Medicines I... | +0.01 | +0.99% |
| PRTGPortage Biotech Inc | +0.22 | +6.92% |
Data as of 3:59pm ET, 05/26/2023
Financials
| Next reporting date | August 3, 2023 |
| EPS forecast (this quarter) | -$0.17 |
| Annual revenue (last year) | $25.9M |
| Annual profit (last year) | -$33.3M |
| Net profit margin | -128.47% |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters Boston, Massachusetts |
Forecasts
